Compare Extra Space Storage, Inc. (EXR) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Twist Bioscience Corp — how do they compare? Extra Space Storage, Inc. trades at $134.5 (market cap $28.12B), while Twist Bioscience Corp trades at $160.9 (market cap $10.08B). The key difference: Extra Space Storage, Inc. is far larger — about 2.8× Twist Bioscience Corp's market cap, and Extra Space Storage, Inc. pays a 4.87% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and Twist Bioscience Corp for 27 Days on average.
| EXR | TWST | |
|---|---|---|
Market Cap | $28.12B | $10.08B |
Volume | 2,595,579 | 4,229,037 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $205.00 |
52-Week Low | $126.67 | $25.45 |
Typical Hold Time | 109 Days | 27 Days |
Enterprise Value | $41.84B | $10.01B |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXR trades at $134.65, up 2.24% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38B in 2025, and net income margin stands at 27.79%. Analyst consensus is split evenly between Buy and Hold, with a price target of $158.33. Recent news highlights leadership transition and dividend declarations.
Outlook is balanced: solid operational performance and dividend yield support the stock, but high valuation ratios and bearish technicals pose near-term risks. Investors should weigh strong fundamentals against potential volatility from interest rate sensitivity and market sentiment shifts.
Twist Bioscience (TWST) trades at $159.78, up 2.65% today, showing strong momentum despite mixed technical signals. The company continues to demonstrate robust revenue growth, with 2025 revenue reaching $377 million, though profitability remains elusive with a -31.66% net income margin. Recent positive developments include a strategic partnership with Eli Lilly's TuneLab AI platform announced September 16, 2026, driving investor optimism about the company's AI-driven drug discovery capabilities.
While analyst consensus remains bullish with 73% buy ratings, the stock faces significant fundamental challenges including persistent cash burn and negative earnings. The current price exceeds the $145.20 consensus target, suggesting limited near-term upside. Key risks include execution challenges in achieving profitability and dependence on AI partnerships for growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
